Is ANT a Good Stock to Buy? The Bull and Bear Case (2026)
Last updated November 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Anthropic, PBC (ANT) rests on Enterprise adoption and agent products: Anthropic's growth comes mainly from businesses. The bear case rests on valuation is the first risk: at ~32 times trailing sales, the price assumes growth that has no precedent at this revenue level, and any slowdown would meet a very high bar. Analysts covering it publish targets from $92.00 to $155.00 against a $88.91 share price on November 20, 2026, so even the professionals disagree by 53% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
ANT key stats
At $88.91 on November 20, 2026, Anthropic, PBC (ANT) has a market cap of $1.17T.
- Market cap
- $1.17T
Market cap, P/E and yield are measured at the $88.91 price on November 20, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.
What's new with Anthropic, PBC (ANT)?
The last two weeks for Anthropic, PBC, as of November 22, 2026: the price move, the next earnings date, and what analysts changed.
- On November 20, 2026, William Blair started coverage at Outperform.
- On November 20, 2026, Seaport Global started coverage at Neutral.
- On November 19, 2026, Citizens started coverage at Market Outperform, target $125.00.
Prices are daily closes from Yahoo Finance. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.
Anthropic, PBC is the AI research company behind Claude. It sells access to its models through an API and the Claude Platform, sells Claude subscriptions to individuals and teams, and sells agent products such as Claude Code, its coding agent, and Claude Cowork, which applies the same approach to office work. Most revenue comes from businesses that build Claude into their own products and workflows. The company was founded in 2021, is headquartered in San Francisco, and is organized as a public benefit corporation, which means its board is legally required to weigh a stated mission alongside shareholder returns. It priced 980 million Class A shares at $83 on November 18, 2026, raising ~$81.3 billion in the base deal, and sold another ~$26.0 billion of non-voting Class N stock to strategic partners in a concurrent private placement. The numbers in the final prospectus explain the size of the offering. Revenue was ~$4.6 billion for all of 2025 and ~$33.2 billion for the first nine months of 2026. The September 2026 quarter alone brought in ~$17.0 billion, up ~1,127% from ~$1.4 billion a year earlier, while compute and infrastructure costs grew ~382%. Anthropic reported run-rate revenue of ~$81 billion at October 31, 2026, and net revenue retention of ~900%. The company is not yet profitable on an operating basis: it earned ~$974 million of operating income in the June quarter, then posted a ~$567 million operating loss in September. Reported net losses are far larger (~$104 billion for nine months) because rising valuations forced non-cash write-ups of convertible notes and other instruments. The shares closed near ~$97.17 on their November 19 debut, after trading as high as ~$115.10, then fell about 13% on November 20 to ~$84.59, about 2% above the IPO price, on a day when the Dow, S&P 500 and Nasdaq all fell and the Nasdaq's correction deepened. At ~$84.59 the market values the company at ~$1.12 trillion on the ~13.2 billion shares outstanding after the offering. That is ~32 times trailing twelve-month revenue of ~$35.3 billion, ~16.5 times the September quarter annualized, and ~14 times the October run rate. Investors are paying for growth to continue at a pace no software company has sustained at this scale, against ~$900.9 billion of compute and infrastructure commitments, a founder group that controls 50.1% of the vote, and a lockup schedule that releases billions of shares through 2027.
The bull case: what would have to be true for $155.00
The most optimistic published target on ANT is $155.00, +74.3% from the $88.91 share price on November 20, 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Enterprise adoption and agent products
Anthropic's growth comes mainly from businesses. The prospectus describes a pattern where a customer starts with one use case and spreads Claude across departments, which shows up as net revenue retention of ~900% at September 30, 2026: existing customers spent roughly nine times what they did a year earlier. Claude Code is the product the company credits most, and the filing says non-technical teams are now adopting Claude Code and Claude Cowork for their own work. Distribution runs through cloud partners, consultancies such as Deloitte, KPMG and PwC, data platforms such as Salesforce and Snowflake, and Ode with Anthropic, a new services company formed with private equity firms to reach mid-sized businesses. Quarterly revenue went from ~$4.7 billion in March 2026 to ~$11.6 billion in June and ~$17.0 billion in September.
2. Compute efficiency and cost per task
The economics depend on how much revenue each dollar of compute produces. In the September 2026 quarter, revenue rose ~1,127% year over year while compute and infrastructure expense rose ~382%, and compute fell from ~148% of revenue a year earlier to ~58%. Anthropic trains and serves models across AWS Trainium, Google TPUs, Nvidia GPUs and AMD GPUs, and moves workloads between them by price and performance. It also says Opus 5.5 cut customer cost per task by ~40% compared with Opus 5, on the theory that cheaper tasks lead to more usage. If that ratio keeps improving, operating margins can open up quickly; the June quarter's ~$974 million operating profit showed it is possible, and September's ~$567 million loss showed it is not yet steady.
3. A very large cash position
Anthropic held ~$95.6 billion of cash and ~$36.3 billion of short-term investments at September 30, 2026, before the IPO. The offering and the concurrent private placement add ~$104.8 billion of estimated net proceeds, or ~$117.0 billion if the underwriters buy all 147 million option shares. That puts the company above ~$230 billion of cash and investments on a pro forma basis, an amount larger than the market value of most S&P 500 companies. Interest income alone was ~$1.25 billion in the September quarter. The cash matters because ~$70.7 billion of compute commitments fall due in the twelve months after September 30, 2026, so the balance sheet can fund the next phase of buildout without the company needing to return to markets soon.
4. Strategic partners with skin in the game
Amazon and Google are both suppliers and owners. After the conversion of preferred stock, Amazon holds ~1.94 billion Class N shares (~14.6% of capital stock) and Google ~1.77 billion (~13.4%); if Amazon's convertible notes converted in full without the ownership cap, Amazon's stake would reach ~23.6%. Class N shares carry no vote and generally convert to Class A only when sold to an unaffiliated buyer. These partners supply chips and cloud capacity and also resell Claude to their own cloud customers, which ties Anthropic's distribution to two of the largest cloud platforms. The relationship cuts both ways: it secures compute and customers, and it concentrates the shareholder base in companies that also build competing models.
The bear case: what would have to be true for $92.00
The most pessimistic published target is $92.00, +3.5% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks Anthropic, PBC is worth if the risks below bite instead of the drivers above.
Valuation is the first risk: at ~32 times trailing sales, the price assumes growth that has no precedent at this revenue level, and any slowdown would meet a very high bar. The second is the ~$900.9 billion of compute and infrastructure commitments, ~$451.6 billion due before 2031, many with take-or-pay terms that require payment whether or not demand shows up. Third, governance limits outside shareholders: the Founder LLC's single Class F share carries 50.1% of the vote, the Long-Term Benefit Trust elects a majority of the board through Class T stock, and the company is a Nasdaq controlled company. Fourth, supply: lockups expire in stages, with ~1.7 billion shares eligible after the FY26 results and ~3.0 billion after Q1 2027 results (or day 180). The board may also issue up to 2% more stock to the Anthropic Public Benefit Fund each time the price rises 50% above the last milestone, starting from $83. Competition from OpenAI and Google, enforcement against customers that violate usage terms (which the filing says could reduce run-rate revenue), copyright litigation (a ~$1.5 billion Bartz settlement was booked in 2025) and AI regulation round out the list. Early trading also shows how volatile a new listing of this size can be: the stock moved from an intraday high of ~$115.10 on day one to ~$84.59 at the close on day two, a range of roughly 27% in two sessions.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding ANT already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on ANT
6 analysts cover ANT, with an average target of $118.93 (+33.8% against $88.91) and a split of 4 buy, 2 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the ANT forecast and price target page.
How is ANT valued?
Market cap, P/E and dividend yield at today's price are in the ANT key stats above. The business figures below come from Anthropic, PBC's reported results as of November 2026 and change when it next reports.
- Revenue (TTM): ~$35.3B
- Revenue (Sep 2026 quarter): ~$17.0B (up ~1,127%)
- Operating loss (TTM): ~$4.1B
- Cash + short-term investments: ~$132B (Sep 30, before IPO)
- Analyst view (6 analysts): Buy; mean target ~$118.93
As of November 2026: Figures come from the November 18, 2026 prospectus; market cap uses ~13.2 billion shares outstanding after the offering and the ~$84.59 close on November 20. Trailing revenue adds the December 2025 quarter (~$2.0 billion) to the first nine months of 2026 (~$33.2 billion). The multiple falls quickly if the run rate holds: ~16.5 times the September quarter annualized and ~14 times the ~$81 billion October run rate. Reported net loss (~$121 billion over twelve months) is dominated by non-cash fair value changes on convertible notes, so operating income is the more useful profit measure here. The six analysts Yahoo tracks so far rate the stock a buy with a mean target near ~$118.93; with only two sessions of trading, that coverage is thin.
How do you decide if ANT is a buy?
Whether ANT is a buy is easier to judge through four narrower questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold ANT indirectly through an index or sector ETF before adding more.
What would change your mind on ANT
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Enterprise adoption and agent products stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
- Bear case breaks if: valuation is the first risk: at ~32 times trailing sales, the price assumes growth that has no precedent at this revenue level, and any slowdown would meet a very high bar fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the ANT stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about ANT against your real portfolio and see your actual exposure before deciding.
Your questions about Anthropic, PBC
Ask Walnut's AI anything about ANT and see how it fits what you own.
FAQ
Is ANT a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Enterprise adoption and agent products, with revenue (ttm) at ~$35.3B. The bear case rests on valuation is the first risk: at ~32 times trailing sales, the price assumes growth that has no precedent at this revenue level, and any slowdown would meet a very high bar. Analysts covering it are spread from $92.00 to $155.00, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.
Should I sell ANT?
+
Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Valuation is the first risk: at ~32 times trailing sales, the price assumes growth that has no precedent at this revenue level, and any slowdown would meet a very high bar. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $92.00, +3.5% from the $88.91 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.
What is the bull case for ANT?
+
Enterprise adoption and agent products. Anthropic's growth comes mainly from businesses. The most optimistic analyst target on ANT is $155.00, +74.3% from the $88.91 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for ANT?
+
Valuation is the first risk: at ~32 times trailing sales, the price assumes growth that has no precedent at this revenue level, and any slowdown would meet a very high bar. The second is the ~$900.9 billion of compute and infrastructure commitments, ~$451.6 billion due before 2031, many with take-or-pay terms that require payment whether or not demand shows up. Third, governance limits outside shareholders: the Founder LLC's single Class F share carries 50.1% of the vote, the Long-Term Benefit Trust elects a majority of the board through Class T stock, and the company is a Nasdaq controlled company. Fourth, supply: lockups expire in stages, with ~1.7 billion shares eligible after the FY26 results and ~3.0 billion after Q1 2027 results (or day 180). The board may also issue up to 2% more stock to the Anthropic Public Benefit Fund each time the price rises 50% above the last milestone, starting from $83. Competition from OpenAI and Google, enforcement against customers that violate usage terms (which the filing says could reduce run-rate revenue), copyright litigation (a ~$1.5 billion Bartz settlement was booked in 2025) and AI regulation round out the list. Early trading also shows how volatile a new listing of this size can be: the stock moved from an intraday high of ~$115.10 on day one to ~$84.59 at the close on day two, a range of roughly 27% in two sessions. The most pessimistic published target is $92.00, +3.5% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.
What does Anthropic, PBC do?
+
AI research company behind the Claude models, listed on Nasdaq in November 2026 at $83 a share.
What would have to change for ANT to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Enterprise adoption and agent products) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (valuation is the first risk: at ~32 times trailing sales, the price assumes growth that has no precedent at this revenue level, and any slowdown would meet a very high bar) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
When did Anthropic go public, and at what price?
+
Anthropic priced its IPO on November 18, 2026 at $83.00 per Class A share, above the $70 to $78 range set when its roadshow launched, and the stock began trading on the Nasdaq Global Select Market under the ticker ANT on November 19. It sold 980 million shares in the base deal: ~956 million new shares from the company and ~23.6 million from selling stockholders, for ~$81.3 billion in gross proceeds. Underwriters, led by Goldman Sachs and Morgan Stanley, have an option to buy up to 147 million more shares. Alongside the IPO, Anthropic sold ~313 million Class N shares to strategic partners for ~$26.0 billion at the same $83 price. The stock closed its first day, November 19, near ~$97.17, about 17% above the IPO price, then fell about 13% on November 20 to ~$84.59, about 2% above it.
How much revenue does Anthropic make?
+
Revenue was ~$41 million in 2023, ~$386 million in 2024 and ~$4.6 billion in 2025. In 2026 the quarters ran ~$4.7 billion (March), ~$11.6 billion (June) and ~$17.0 billion (September), for ~$33.2 billion in nine months, compared with ~$2.5 billion in the same period of 2025. Trailing twelve-month revenue through September 30, 2026 is ~$35.3 billion. The prospectus also gives run-rate revenue of ~$81 billion at October 31, 2026, up ~$10 billion from a month earlier. Run rate annualizes a recent period, so it can move up or down quickly, and the filing warns that it includes revenue from customers who may later be cut off for violating usage terms.
Is Anthropic profitable?
+
Not yet on a full-year basis. Operating loss was ~$8.1 billion in 2025 (including a ~$1.5 billion Bartz copyright settlement) and ~$1.3 billion for the first nine months of 2026. Within that, the June 2026 quarter showed ~$974 million of operating income and the September quarter a ~$567 million operating loss, as compute, sales and administrative costs all rose. Reported net loss is much larger, ~$104 billion for nine months of 2026, because the company had to mark its convertible notes and related instruments up to its rising valuation; those were non-cash charges, and the notes convert to stock at the IPO. Stock-based compensation was ~$3.3 billion in the nine months, with ~$7.5 billion more recognized pro forma once IPO-linked RSUs vested.
Walnut is informational, not investment advice, and gives no verdict on ANT. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. The share price is the last one Yahoo Finance reported on November 20, 2026. Verify current figures with your broker before acting on them.